Vergleich

Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)

ArtNr ELS-PKSH031899-100ug
Hersteller Elabscience
Menge 100 ug
Quantity options 100 ug 200 ug 1 mg
Kategorie
Typ Proteins
Format Lyophilized Powder
Applikationen Cell Culture
Specific against Human (Homo sapiens)
Host HEK293 cells
Konjugat/Tag C-hFc
Purity > 97 % as determined by reducing SDS-PAGE.
Sequence Met 1-Gln 118
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias ACVRL1, ACVRLK1, ALK-1, ALK1, Activin Receptor-Like Kinase 1, HHT, HHT2, ORW2, SKR3, Serine/Threonine-Protein Kinase Receptor R3, TGF-B Superfamily Receptor Type I, TSR-I
Similar products ACVRL1, ACVRLK1, ALK1, HHT2, ALK-1, HHT, ORW2, SKR3, TSR-I, Serine/Threonine-Protein Kinase Receptor R3, TGF-B Superfamily Receptor Type I, Activin Receptor-Like Kinase 1
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Category
Recombinant Proteins / Others
Manufacturer - Conjugate / Tag
C-hFc
Shipping Temperature
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Calculated Molecular Weight
37.4 kDa
Observed Molecular Weight
45-50 kDa
Manufacturer - Research Areas
Signal Transduction, Cardiovascular, Cancer, metabolism,
Background
Activin A receptor, type II-like 1 (ACVRL1), also known as ALK-1 (activin receptor-like kinase 1), is an endothelial-specific type I receptor of the TGF-beta (transforming growth factor beta) receptor family of ligands. On ligand binding, a heteromeric receptor complex forms consisting of two type II and two type I transmembrane serine/threonine kinases. ACVRL1 protein is expressed in certain blood vessels of kidney, spleen, heart and intestine, serving as an important role during vascular development. Mutations in ACVRL1 gene are associated with hemorrhagic telangiectasia type 2, also known as Rendu-Osler-Weber syndrome 2 and vascular disease.
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method.
Reconstitution
Please refer to the printed manual for detailed information.
Formulation
Lyophilized from sterile PBS, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Activity
1. Measured by its ability to bind Human ENG-Fc, latent TGFB1-His, mouse ENG-His in functional Elisa. 2. Measured by its ability to inhibit BMP9 induced alkaline phosphatase production by MC3T3E1 mouse chondrogenic cells. David, L. et al. (2007) Blood 109:1953. The ED50 for this effect is typically 5-15 ng/mL in the presence of 2 ng/mL of recombiant human BMP9.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?